Investigation of Inogen, Inc.

Inogen, Inc. (INGN) Accused of Misstating its Strong Sales and Financial Success

On November 7, 2017, Inogen, Inc. (INGN) touted its strong sales and financial success, predicting “strong results in 2018…” and increased its guidance range for full year 2017 revenue.  Inogen subsequently increased its FY18 guidance range, emphasizing that the company’s strong direct-to-customer sales were the result of the strong sales acumen of its salesforce. These quarterly statements were often followed by significant increases in stock price that resulted in a class period high of more than $282 per share on September 14, 2018.  In February 2019, a series of news articles were released criticizing the company’s narrative and denouncing its sales tactics, negatively affecting the company’s stock.  Then, on February 26, 2019, Inogen announced poor 4Q18 and FY18 financial results, which caused Inogen’s stock to fall nearly $34 per share, or more than 24% to close at $106.28 per share on February 27, 2019.  As of October 11, 2019, the stock trades around $48 per share, representing another 57% decline in value.

If you are a former employee of Inogen, Inc. (INGN) and own stock, please contact us for more information about your rights and potential remedies.

Send us a message for more information.